Hermann Claus

Hermann Claus

Auto-generated profile, based on publicly available information

Hermann Claus

Department of Infectious Disease Epidemiology, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
DHDag Harmsen
Dag Harmsen
HCHeike Claus
Heike Claus
WWWolfgang Witte
Wolfgang Witte
JRJörg Rothgänger
Jörg Rothgänger
HCHermann Claus
Hermann Claus
UVUlrich Vogel
Ulrich Vogel
The spa gene of Staphylococcus aureus encodes protein A and is used for typing of methicillin-resistant Staphylococcus aureus (MRSA). We used sequence typing of the spa gene repeat region to study the epidemiology of MRSA at a German university hospital. One hundred seven and 84 strains were studied during two periods of 10 and 4 months, respectively. Repeats and spa types were determined by Ridom StaphType, a novel software tool allowing rapid repeat determination, data management and retrieval, and Internet-based assignment of new spa types following automatic quality control of DNA sequence chromatograms. Isolates representative of the most abundant spa types were subjected to multilocus sequence typing and pulsed-field gel electrophoresis. One of two predominant spa types was replaced by a clonally related variant in the second study period. Ten unique spa types, which were equally distributed in both study periods, were recovered. The data show a rapid dynamics of clone circulation in a university hospital setting. spa typing was valuable for tracking of epidemic isolates. The data show that disproval of epidemiologically suggested transmissions of MRSA is one of the main objectives of spa typing in departments with a high incidence of MRSA.

1 March 1999 in Microbial Drug Resistance
Verified
Journal Article
Closed access
IKI. Klare
I. Klare
DBD. Badstübner
D. Badstübner
CKC. Konstabel
C. Konstabel
GBG. Böhme
G. Böhme
HCH. Claus
H. Claus
WWW. Witte
W. Witte
The use of the glycopeptide antibiotic avoparcin (AVO) as a feed additive in animal husbandry of many European countries led in 1994–1995 to frequent isolation of VanA-type vancomycin-resistant enterococci (VRE) from commercially produced animal foodstuffs as well as from fecal samples of nonhospitalized persons in Germany (Saxony-Anhalt state). However, at the end of 1997, a decreasing number of such VRE was detected in frozen and fresh poultry meat (chickens and turkeys) from German producers. At this point in time, AVO had been discontinued in animal husbandry for more than 2 and one-half years in Denmark/Norway, nearly 2 years in Germany, and about 8–9 months in all countries of the European Community and Switzerland, respectively. VRE were then only detected in very low concentrations in one-quarter of the poultry meat samples (eight of 31, originating from 18 distinct German producers and bought in 12 different supermarkets). A decline of VRE prevalence was also observed in the gut flora of healthy persons (VRE carriers) in the same region (Saxony-Anhalt state, Germany), having fallen from 12% (12/100) in 1994 when AVO was being used to 6% (6/100) in 1996 and 3% (13/400) in 1997 after it was discontinued. These results likely indicate the importance of antibiotic selective pressure by glycopeptides such as AVO for the presence of VRE in animal meat products from commercial animal husbandry. Additionally, it underlines the role of animal products for the spread of resistant bacteria and transferable resistance genes to humans in the community.

1 October 1995 in Microbial Drug Resistance
Verified
Journal Article
Closed access
IKI. Klare
I. Klare
HHH. Heier
H. Heier
HCH. Claus
H. Claus
GBG. Böhme
G. Böhme
SMS. Marin
S. Marin
WWW. Witte
W. Witte
The occurrence and the further spread of high-level glycopeptide-resistant, vanA -positive Enterococcus faecium strains outside of hospitals have been investigated. We could isolate such bacteria directly from thawing liquids of commercially produced frozen poultry (chickens, turkeys; no further data on previous feeding with avoparcin were available). In 5 of 13 samples of raw minced meat of pigs originating from 13 different butcher's shops, glycopeptide-resistant E. faecium (VanA type) could be detected after overnight broth cultivation of these samples. No glycopeptide-resistant enterococci could be isolated from meat samples of chickens that were fed without avoparcin. VanA type E. faecium strains were also identified in 12 fecal samples recovered from 100 nonhospitalized humans in the rural area of Saxony-Anhalt federal county. These results suggest a possible role of the food chain in the spread of glycopeptide-resistant E. faecium . Molecular typing (macrorestriction and multilocus enzyme analysis) reveal a wide dissemination of the vanA gene among strains of different ecological origins.

1 October 2007 in Emerging Infectious Diseases
Verified
Journal Article
Open access
GKGérard Krause
Gérard Krause
DADoris Altmann
Doris Altmann
DFDaniel Faensen
Daniel Faensen
KPKlaudia Porten
Klaudia Porten
JBJustus Benzler
Justus Benzler
HCHermann Claus
Hermann Claus
In 2001, the Robert Koch Institute (RKI) implemented a new electronic surveillance system (SurvNet) for infectious disease outbreaks in Germany. SurvNet has captured 30,578 outbreak reports in 2001–2005. The size of the outbreaks ranged from 2 to 527 cases. For outbreaks reported in 2002–2005, the median duration from notification of the first case to the local health department until receipt of the outbreak report at RKI was 7 days. Median outbreak duration ranged from 1 day (caused by Campylobacter) up to 73 days (caused by Mycobacterium tuberculosis). The most common settings among the 10,008 entries for 9,946 outbreaks in 2004 and 2005 were households (5,262; 53%), nursing homes (1,218; 12%), and hospitals (1,248; 12%). SurvNet may be a useful tool for other outbreak surveillance systems because it minimizes the workload of local health departments and captures outbreaks even when causative pathogens have not yet been identified.

26 March 2015 in Eurosurveillance
Verified
Journal Article
Open access
CFC Fähnrich
C Fähnrich
KDKerstin Denecke
Kerstin Denecke
OAO O Adeoye
O O Adeoye
JBJ Benzler
J Benzler
HCH Claus
H Claus
GKG Krause
G Krause
Binary file ES_Abstracts_Final_ECDC.txt matches

1 July 2009 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
ARAnnicka M. Reuss
Annicka M. Reuss
MWMiriam Wiese-Posselt
Miriam Wiese-Posselt
BWBarbara Weimann
Barbara Weimann
ASAnette Siedler
Anette Siedler
IZIrina Zuschneid
Irina Zuschneid
WHWalter H. Haas
Walter H. Haas
An increasing incidence in disease caused by nontuberculous mycobacteria is being reported. We investigated the burden of disease in immunocompetent German children in a prospective nationwide study from April 2003 to September 2005. Ninety-seven percent of children presented with lymphadenitis; median age was 2.5 years. Using the capture-recapture method, we estimated a cumulative incidence rate of 3.1/100000 children.